Download PTU B.Pharmacy 2020 March 8th Sem 72296 Pharmaceutics IX Question Paper

Download PTU (I.K. Gujral Punjab Technical University Jalandhar (IKGPTU) ) B.Pharma (Bachelor of Pharmacy) 2020 March 8th Sem 72296 Pharmaceutics IX Previous Question Paper

1 | M-72296 (S4)-1615

Roll No. Total No. of Pages : 02
Total No. of Questions : 10
B.Pharma (2012 to 2016) (Sem.?8)
PHARMACEUTICS-IX (DOSAGE FORM DESIGN)
Subject Code : BPHM-801
M.Code : 72296

Time : 3 Hrs. Max. Marks : 80
INSTRUCTIONS TO CANDIDATES :
1. SECTION-A is COMPULSORY consisting of FIFTEEN questions carrying TWO
marks each.
2. SECTION-B contains FIVE questions carrying FIVE marks each and students
have to attempt any FOUR questions.
3. SECTION-C contains FOUR questions carrying TEN marks each and students
have to attempt any THREE questions.

SECTION-A
1. Answer briefly :
a. Describe the role of solubility in preformulation studies.
b. Define bioequivalence.
c. Define polymorphism.
d. Define dissolution.
e. Define bioavailability.
f. Name any two drugs prone to hydrolysis.
g. Define solvates.
h. Name any two drugs prone to oxidation.
i. Explain hydrates.
j. Define prodrugs.
FirstRanker.com - FirstRanker's Choice
1 | M-72296 (S4)-1615

Roll No. Total No. of Pages : 02
Total No. of Questions : 10
B.Pharma (2012 to 2016) (Sem.?8)
PHARMACEUTICS-IX (DOSAGE FORM DESIGN)
Subject Code : BPHM-801
M.Code : 72296

Time : 3 Hrs. Max. Marks : 80
INSTRUCTIONS TO CANDIDATES :
1. SECTION-A is COMPULSORY consisting of FIFTEEN questions carrying TWO
marks each.
2. SECTION-B contains FIVE questions carrying FIVE marks each and students
have to attempt any FOUR questions.
3. SECTION-C contains FOUR questions carrying TEN marks each and students
have to attempt any THREE questions.

SECTION-A
1. Answer briefly :
a. Describe the role of solubility in preformulation studies.
b. Define bioequivalence.
c. Define polymorphism.
d. Define dissolution.
e. Define bioavailability.
f. Name any two drugs prone to hydrolysis.
g. Define solvates.
h. Name any two drugs prone to oxidation.
i. Explain hydrates.
j. Define prodrugs.
2 | M-72296 (S4)-1615

k. Discuss the importance of student?s T test.
l. Name any two approaches for solubility enhancement.
m. Define absolute and relative bioavailability.
n. What are controlled release dosage forms?
o. What are biodegradable polymers?

SECTION-B
2. What are the polymers used for enteric coated tablets? Discuss the in vitro testing of
enteric coated tablets.
3. Discuss various factors affecting the oxidation of drugs.
4. What is BCS? Discuss various classes along with suitable example.
5. What are the prominent features of quality assurance?
6. Explain the rationale for retrospective validation. Also, discuss the process briefly.

SECTION-C
7. Discuss preformulation studies. Enlist the various properties of the drugs to be considered
while performing the preformulation studies.
8. Discuss the ICH guidelines for accelerated stability studies.
9. Classify oral controlled release drug delivery system.
10. Explain the application of prodrugs in various pharmaceutical fields.

NOTE : Disclosure of Identity by writing Mobile No. or Making of passing request on any
page of Answer Sheet will lead to UMC against the Student.
FirstRanker.com - FirstRanker's Choice